TSXV:TRL.H - Post by User
Post by
segltechon May 30, 2014 12:29pm
290 Views
Post# 22615165
Analyst's upgrades and downgrades
Analyst's upgrades and downgradesRBC Dominion Securities raised its target on Trimel Pharmaceuticals to $1.50 (Canadian) from $1 and reiterated an "outperform" rating Paradigm raised its target to $2.25 from $1.75 and maintained a "buy" rating.